Home › Lymphatic Abnormalities › North Carolina
Lymphatic Abnormalities clinical trials in North Carolina
3 studies for Lymphatic Abnormalities are looking for participants at sites in North Carolina.
Cities in North Carolina
A Study to Investigate Efficacy and Safety of KP-001 Compared With Placebo in Patients Aged ≥2 Years With Common VM, Common LM, or KTS/CLOVES Syndrome
- UNC Health Care - North Carolina Children's Hospital, Chapel Hill
RecruitingPhase 3
Ages 2 and older · All sexes · Updated Nov 12, 2026 · NCT07285005A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
- UNC Chapel Hill, Chapel Hill
RecruitingPhase 2
Ages 2 and older · All sexes · Updated Nov 12, 2026 · NCT06789913Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
- University of North Carolina at Chapel Hill, Chapel Hill
RecruitingPhase 2/3
Ages 0 to 100 · All sexes · Updated Oct 9, 2026 · NCT05948943From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.